Picture of Agenus logo

AGEN — Agenus News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapTurnaround

Agenus Inc expected to post a loss of $2.54 a share - Earnings Preview

Agenus Inc AGEN.OQ AGEN.O is expected to show a fall in quarterly revenue when it reports  results on March 11 for the period ending December 31 2024

The Lexington Massachusetts-based  company is expected to report a 63.9% decrease in revenue to $30.272 million from $83.8 million a year ago, according to the mean estimate from 5 analysts, based on LSEG data.

​LSEG's mean analyst estimate for Agenus Inc is for a loss of $2.54 per share.

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy," 4 "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Agenus Inc is $7.00​, above​ its last closing price of $2.35. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDINGSTARMINESMARTESTIMATE®LSEG IBES ESTIMATEACTUALBEAT, MET, MISSEDSURPRISE %
Sep. 30 2024-2.43-2.33-3.08Missed-32.1
Jun. 30 2024-1.94-1.44-2.52Missed-74.7
Mar. 31 2024-3.17-3.22-3.04Beat5.5​
Dec. 31 2023-1.05-2.60Missed-147.6
​​Sep. 30 2023-3.86-3.84-3.20Beat16.7
Jun. 30 2023-3.84-3.97-4.00Missed-0.8​
Mar. 31 2023-4.27-4.20-4.40Missed-4.8
Dec. 31 2022-4.57-4.37-4.80Missed-9.9
This summary was machine generated March 7 at 13:28 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on Agenus

See all news